Jerzy Bogdan Gajewski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jerzy Bogdan Gajewski has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Marcio Augusto Averbeck
Pontíficia Universidade Católica do Rio Grande do Sul, Brasil; Hospital Moinhos de Vento, Brasil
4 shared publications - Brigitte Schurch
Lausanne University Hospital (CHUV)
3 shared publications - Enrico Finazzi Agrò
Urology Unit, Department of Surgical Sciences, Tor Vergata University Hospital, University of Rome Tor Vergata, Rome, Italy
3 shared publications - Marcus John Drake
Department of Surgery and Cancer, Imperial College, London, UK
3 shared publications - Ali A. Al-Zahrani
Urology Department, Dalhousie University, Halifax, NS
2 shared publications - Andrew Gammie
Bristol Urological Institute Southmead Hospital Bristol UK
2 shared publications
Latest Publications
- 24 December 2024
- Published by Wiley in Neurourology and Urodynamics
- Vol. 44 (3) , 637-643
Can We Prevent Recurrent UTIs Without Antibiotics, in Both Those Who Do and Do Not Use Catheters? ICI‐RS 2024
Aims: Urinary tract infections are one of the most common reasons for antibiotic prescription. The widespread use of antibiotic treatments contributes to the global health problem of antimicrobial resistance development. To slow down the progression of antimicrobial resistance, it is essential that we explore nonantibiotic preventive treatments for this common condition. We aim to report discussions regarding nonantibiotic preventive strategies for recurrent urinary tract infections in both catheterized and non‐catheterized patients that took place at the International Consultation on Incontinence—Research Society meeting in Bristol in 2024.Methods: We undertook a think‐tank session during this multidisciplinary meeting specifically designated for discussion regarding both established and emerging nonantibiotic treatments for UTI prevention in both catheterized and non‐catheterized patients. This led to the generation of pertinent research questions, which hope to shape future UTI research.Results: We describe the discussions that took place and document the important research questions that were proposed during the International Consultation on Incontinence‐Research Society meeting in Bristol in 2024.Conclusions: There is a range of established UTI preventative strategies for UTI prevention in both catheterized and non‐catheterized patients. Emerging UTI prevention treatments have varying levels of evidence to support their use, and in many areas, further research is needed to establish their place in clinical pathways.
- 24 December 2024
- Published by Wiley in Neurourology and Urodynamics
- Vol. 44 (3) , 637-643
Can We Prevent Recurrent UTIs Without Antibiotics, in Both Those Who Do and Do Not Use Catheters? ICI‐RS 2024
Aims: Urinary tract infections are one of the most common reasons for antibiotic prescription. The widespread use of antibiotic treatments contributes to the global health problem of antimicrobial resistance development. To slow down the progression of antimicrobial resistance, it is essential that we explore nonantibiotic preventive treatments for this common condition. We aim to report discussions regarding nonantibiotic preventive strategies for recurrent urinary tract infections in both catheterized and non‐catheterized patients that took place at the International Consultation on Incontinence—Research Society meeting in Bristol in 2024.Methods: We undertook a think‐tank session during this multidisciplinary meeting specifically designated for discussion regarding both established and emerging nonantibiotic treatments for UTI prevention in both catheterized and non‐catheterized patients. This led to the generation of pertinent research questions, which hope to shape future UTI research.Results: We describe the discussions that took place and document the important research questions that were proposed during the International Consultation on Incontinence‐Research Society meeting in Bristol in 2024.Conclusions: There is a range of established UTI preventative strategies for UTI prevention in both catheterized and non‐catheterized patients. Emerging UTI prevention treatments have varying levels of evidence to support their use, and in many areas, further research is needed to establish their place in clinical pathways.
- 10 October 2024
- Published by Wiley in Neurourology and Urodynamics
- Vol. 44 (3) , 676-682
Is Our Limited Understanding of the Effects of Nerve Stimulation Resulting in Poor Outcomes and the Need for Better “Rescue Programming” in SNM and PTNS, and Lost Opportunities for New Sites of Stimulation? ICI‐RS 2024
Aims: Sacral neuromodulation (SNM) and percutaneous tibial nerve stimulation (PTNS) are strongly recommended by international guidelines bodies for complex lower urinary tract dysfunctions. However, treatment failure and the need for rescue programming still represent a significant need for long‐term follow‐up. This review aimed to describe current strategies and future directions in patients undergoing such therapies.Materials and Methods: This is a consensus report of a Think Tank discussed at the Annual Meeting of the International Consultation on Incontinence – Research Society (ICI‐RS), June 6–8, 2024 (Bristol, UK): “Is our limited understanding of the effects of nerve stimulation resulting in poor outcomes and the need for better ‘rescue programming’ in SNM and PTNS, and lost opportunities for new sites of stimulation?”Results: Rescue programming is important from two different perspectives: to improve patient outcomes and to enhance device longevity (for implantable devices). Standard SNM parameters have remained unchanged since its inception for the treatment of OAB, nonobstructive urinary retention, and voiding dysfunction. SNM rescue programming includes intermittent stimulation (cycling on), increased frequency and changes in pulse width (PW). The effect of PW setting on SNM outcomes remains unclear. Monopolar configurations stimulate more motor nerve fibers at lower stimulation voltage; hence, this could be an option in patients who failed bipolar stimulation in the long term. Unfortunately, there is little evidence for rescue programming for PTNS. However, the development of implantable devices for intermittent stimulation of the tibial nerve may increase long‐term adherence to therapy and increase interest in alternative programming. There has been recent promising neurostimulation targeting the pudendal nerve (PNS), especially in BPS/IC. More recently, preliminary data addressed the benefits of high‐frequency bilateral pudendal nerve block for DESD and adaptive PNS on both urgency and stress UI in women.Conclusion: The exploration of rescue programming and new stimulation sites remains underutilized, and there are opportunities that could potentially expand the therapeutic applications of nerve stimulation. By broadening the range of target sites, clinicians may be able to tailor treatments according to individual patient needs and underlying conditions, thereby improving overall outcomes. However, further studies are still needed to increase the level of evidence, potentially allowing for an individualized treatment both in patients who are candidates for electrostimulation and in those who have already received surgical implants but seek a better outcome.
- 10 October 2024
- Published by Wiley in Neurourology and Urodynamics
- Vol. 44 (3) , 676-682
Is Our Limited Understanding of the Effects of Nerve Stimulation Resulting in Poor Outcomes and the Need for Better “Rescue Programming” in SNM and PTNS, and Lost Opportunities for New Sites of Stimulation? ICI‐RS 2024
Aims: Sacral neuromodulation (SNM) and percutaneous tibial nerve stimulation (PTNS) are strongly recommended by international guidelines bodies for complex lower urinary tract dysfunctions. However, treatment failure and the need for rescue programming still represent a significant need for long‐term follow‐up. This review aimed to describe current strategies and future directions in patients undergoing such therapies.Materials and Methods: This is a consensus report of a Think Tank discussed at the Annual Meeting of the International Consultation on Incontinence – Research Society (ICI‐RS), June 6–8, 2024 (Bristol, UK): “Is our limited understanding of the effects of nerve stimulation resulting in poor outcomes and the need for better ‘rescue programming’ in SNM and PTNS, and lost opportunities for new sites of stimulation?”Results: Rescue programming is important from two different perspectives: to improve patient outcomes and to enhance device longevity (for implantable devices). Standard SNM parameters have remained unchanged since its inception for the treatment of OAB, nonobstructive urinary retention, and voiding dysfunction. SNM rescue programming includes intermittent stimulation (cycling on), increased frequency and changes in pulse width (PW). The effect of PW setting on SNM outcomes remains unclear. Monopolar configurations stimulate more motor nerve fibers at lower stimulation voltage; hence, this could be an option in patients who failed bipolar stimulation in the long term. Unfortunately, there is little evidence for rescue programming for PTNS. However, the development of implantable devices for intermittent stimulation of the tibial nerve may increase long‐term adherence to therapy and increase interest in alternative programming. There has been recent promising neurostimulation targeting the pudendal nerve (PNS), especially in BPS/IC. More recently, preliminary data addressed the benefits of high‐frequency bilateral pudendal nerve block for DESD and adaptive PNS on both urgency and stress UI in women.Conclusion: The exploration of rescue programming and new stimulation sites remains underutilized, and there are opportunities that could potentially expand the therapeutic applications of nerve stimulation. By broadening the range of target sites, clinicians may be able to tailor treatments according to individual patient needs and underlying conditions, thereby improving overall outcomes. However, further studies are still needed to increase the level of evidence, potentially allowing for an individualized treatment both in patients who are candidates for electrostimulation and in those who have already received surgical implants but seek a better outcome.
- 26 October 2023
- Published by Springer Nature
- p. 233-242
Endoscopic Evaluation of Neurogenic Bladder
- 26 October 2023
- Published by Springer Nature
- p. 143-153
Classification and Terminology of Neurogenic LUT Dysfunction
- 26 October 2023
- Published by Springer Nature
- p. 143-153
Classification and Terminology of Neurogenic LUT Dysfunction
- 26 October 2023
- Published by Springer Nature
- p. 215-227
Imaging Techniques in the Evaluation of the Neurogenic Lower Urinary Tract Dysfunction (NLUTD)
- 26 October 2023
- Published by Springer Nature
- p. 215-227
Imaging Techniques in the Evaluation of the Neurogenic Lower Urinary Tract Dysfunction (NLUTD)
- 12 October 2022
- Published by Springer Nature
- p. 1-14
Endoscopic Evaluation of Neurogenic Bladder
- Open Access
- 3 February 2022
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 20, eAE5680
Tradução para o português An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD)
RESUMO Introdução A terminologia para disfunção neurogênica do trato urinário inferior em adultos (DNTUIA) deve ser definida e organizada com base clínica em um relatório de consenso. Métodos Este relatório foi criado por um Grupo de Trabalho sob o endosso e diretrizes do Standardization Steering Committee (SSC) da International Continence Society (ICS), auxiliado em intervalos por julgadores externos. Todas as definições relevantes para DNTUIA foram atualizadas com base em pesquisas nos últimos 14 anos. Um extenso processo de 18 rodadas
- 3 February 2022
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 20, eAE5680
Open AccessTradução para o português An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD)
RESUMO Introdução A terminologia para disfunção neurogênica do trato urinário inferior em adultos (DNTUIA) deve ser definida e organizada com base clínica em um relatório de consenso. Métodos Este relatório foi criado por um Grupo de Trabalho sob o endosso e diretrizes do Standardization Steering Committee (SSC) da International Continence Society (ICS), auxiliado em intervalos por julgadores externos. Todas as definições relevantes para DNTUIA foram atualizadas com base em pesquisas nos últimos 14 anos. Um extenso processo de 18 rodadas
- 1 January 2022
- Published by Springer Nature
- p. 1-12
Classification and Terminology of Neurogenic LUT Dysfunction
- 1 January 2022
- Published by Springer Nature
- p. 1-12
Classification and Terminology of Neurogenic LUT Dysfunction
- 1 January 2022
- Published by Springer Nature
- p. 1-14
Imaging Techniques in the Evaluation of the Neurogenic Lower Urinary Tract Dysfunction (NLUTD)
- 1 January 2022
- Published by Springer Nature
- p. 1-14
Imaging Techniques in the Evaluation of the Neurogenic Lower Urinary Tract Dysfunction (NLUTD)
- 24 November 2020
- Published by Wiley in Neurourology and Urodynamics
- Vol. 40 (1) , 461-469
Long‐term outcomes of sacral neuromodulation for lower urinary tract dysfunction: A 23‐year experience
Aims: To evaluate the long‐term outcomes of sacral neuromodulation (SNM), and patient characteristics that may predict long‐term success or complications.Methods: A single‐center retrospective cohort study was performed of all patients who underwent SNM testing and implantation. Outcome results, resolution of symptoms, and device removal were reported. Multivariable logistic regression was used to identify predictors of success. Cox proportional hazards model was used to identify predictors for device removal.Results: Four hundred and thrity four patients underwent SNM test phase of which 241 (median age 48.0 years, 91.7% [221/241] female) had device implantation and were followed up for median [range] time of 4.0 (3 months–20.5 years) years. Multivariable logistic regression showed that male gender (odds ratio: 0.314; 95% confidence interval: 0.164–0.601, p = .0005) was independently associated with decreased peripheral nerve evaluation success. At final follow‐up for patients who originally had device implantation, median (interquartile range) percent of symptoms resolution of all patients was 60.0% (0%–90%) and 69.3% (167/241) had SNM successful outcomes. Cox proportional hazards model showed no difference for time to SNM device removal with respect to patient age, gender, or diagnosis. 69.3% (167/241) patients had at least 1 surgical re‐intervention. The most common reason at first surgical re‐intervention was lead change only (26.3%, 44/167).Conclusion: SNM is a minimally invasive procedure with good long‐term success rates. There is a high revision rate but overall, SNM has a good safety profile and excellent long‐term outcomes.
- 24 November 2020
- Published by Wiley in Neurourology and Urodynamics
- Vol. 40 (1) , 461-469
Long‐term outcomes of sacral neuromodulation for lower urinary tract dysfunction: A 23‐year experience
Aims: To evaluate the long‐term outcomes of sacral neuromodulation (SNM), and patient characteristics that may predict long‐term success or complications.Methods: A single‐center retrospective cohort study was performed of all patients who underwent SNM testing and implantation. Outcome results, resolution of symptoms, and device removal were reported. Multivariable logistic regression was used to identify predictors of success. Cox proportional hazards model was used to identify predictors for device removal.Results: Four hundred and thrity four patients underwent SNM test phase of which 241 (median age 48.0 years, 91.7% [221/241] female) had device implantation and were followed up for median [range] time of 4.0 (3 months–20.5 years) years. Multivariable logistic regression showed that male gender (odds ratio: 0.314; 95% confidence interval: 0.164–0.601, p = .0005) was independently associated with decreased peripheral nerve evaluation success. At final follow‐up for patients who originally had device implantation, median (interquartile range) percent of symptoms resolution of all patients was 60.0% (0%–90%) and 69.3% (167/241) had SNM successful outcomes. Cox proportional hazards model showed no difference for time to SNM device removal with respect to patient age, gender, or diagnosis. 69.3% (167/241) patients had at least 1 surgical re‐intervention. The most common reason at first surgical re‐intervention was lead change only (26.3%, 44/167).Conclusion: SNM is a minimally invasive procedure with good long‐term success rates. There is a high revision rate but overall, SNM has a good safety profile and excellent long‐term outcomes.